Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Horwitz
    Horwitz
  2. Sadelain
    Sadelain
  3. Slovin
    Slovin
  4. Arcila
    Arcila
  5. Levine
    Levine
  6. Abdel-Wahab
    Abdel-Wahab
  7. Castro-Malaspina
    Castro-Malaspina
  8. Giralt
    Giralt
  9. O'Reilly
    O'Reilly
  10. Zelenetz
    Zelenetz

Groups

  1. Hematologic Malignancies, Division of (280)
  2. Department of Medicine (279)
  3. Center for Hematologic Malignancies (208)
  4. GSK Faculty (86)
  5. Adult Leukemia (67)
  6. Sloan Kettering Institute Faculty (61)
  7. Solid Tumor Oncology Division (57)
  8. Lymphoma (56)
  9. Bone Marrow Transplant (49)
  10. Executive Committee, Center for Hematologic Malignancies (45)
Search Within
  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (154)
  2. Meeting Abstract (101)
  3. Review (14)
  4. Correspondence (4)
  5. Editorial (3)
  6. Guidelines (3)
  7. Research Letter (1)
Groups
  1. Hematologic Malignancies, Division of (280)
  2. Department of Medicine (279)
  3. Center for Hematologic Malignancies (208)
  4. GSK Faculty (86)
  5. Adult Leukemia (67)
  6. Sloan Kettering Institute Faculty (61)

More Groups

People
  1. Steven Horwitz (18)
  2. Michel Sadelain (16)
  3. Susan Slovin (14)
  4. Maria Arcila (13)
  5. Ross Levine (12)
  6. Anas Younes (11)

More People

Years
  1. 2025 (6)
  2. 2024 (16)
  3. 2023 (21)
  4. 2022 (15)
  5. 2021 (19)
  6. 2020 (26)

More Years

Publications
  1. Experimental Hematology (62)
  2. Lancet Oncology (46)
  3. The Lancet Haematology (32)
  4. Value in Health (21)
  5. Journal of Molecular Diagnostics (19)
  6. Lancet (14)

More Publications

Results (280)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: A prospective cohort study from the international T-cell Project
    Journal Article

    Fox, C. P.; Civallero, M.; Ko, Y. H.; Manni, M.; Skrypets, T.; Pileri, S.; Kim, S. J.; Cabrera, M. E.; Shustov, A. R.; Chiattone, C. S.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cell therapy in prostate cancer: Reality or folly?
    Editorial

    Slovin, S. F.
    European Urology (2020)

    Fulltext@MSK | Save
  • Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): A two-arm, randomised, open-label, phase 2 study
    Journal Article

    Lonial, S.; Lee, H. C.; Badros, A.; Trudel, S.; Nooka, A. K.; Chari, A.; Abdallah, A. O.; Callander, N.; Lendvai, N.; Sborov, D.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cell therapy for cancer and heart
    Review

    Ganatra, S.; Carver, J. R.; Hayek, S. S.; Ky, B.; Leja, M. J.; Lenihan, D. J.; Lenneman, C.; Mousavi, N.; Park, J. H.; Perales, M. A.; more...
    Journal of the American College of Cardiology (2019)

    Fulltext@MSK | Save
  • CCR4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders and its implications for diagnosis and treatment
    Meeting Abstract

    Geller, S.; Hollmann, T. J.; Horwitz, S. M.; Myskowski, P. L.; Pulitzer, M.
    Journal of Investigative Dermatology (2019)

    Fulltext@MSK | Save
  • Will GALEN become more RELEVANT?
    Editorial

    von Keudell, G.; Younes, A.
    The Lancet Haematology (2019)

    Fulltext@MSK | Save
  • Cost-effectiveness of a 24-month fixed duration of venetoclax in combination with rituximab in relapsed or refractory chronic lymphocytic leukemia in the United States
    Meeting Abstract

    Huntington, S. F.; Strunz-McKendry, T.; Masaquel, A. S.; Shapouri, S.; Sail, K.; Durno, N.; Mato, A.
    Value in Health (2019)

    Fulltext@MSK | Save
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  • Neoadjuvant systemic therapy in melanoma: Recommendations of the International Neoadjuvant Melanoma Consortium
    Guidelines

    Amaria, R. N.; Menzies, A. M.; Burton, E. M.; Scolyer, R. A.; Tetzlaff, M. T.; Antdbacka, R.; Ariyan, C.; Bassett, R.; Carter, B.; Daud, A.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: A retrospective, pooled cohort study with external validations
    Journal Article

    Soumerai, J. D.; Ni, A.; Darif, M.; Londhe, A.; Xing, G.; Mun, Y.; Kay, N. E.; Shanafelt, T. D.; Rabe, K. G.; Byrd, J. C.; more...
    The Lancet Haematology (2019)

    Fulltext@MSK | Save